Search Results for "predictive value of tests"

Experiment #00000080

Prenatal iron deficiency (ID) exacerbates the risk of sudden infant death syndrome (SIDS) by modulating the expression of the hypothalamic orexin system, impairing homeostatic arousal mechanisms during hypoxia.

Anemia, Iron-Deficiency _gates_from_anemia__iron_deficiency Hypothalamic-Hypophyseal System _gates_to_hypothalamic_hypophyseal_system _gates_from_hypothalamic_hypophyseal_system Sudden Infant Death _gates_to_sudden_infant_death _gates_from_sudden_infant_death Orexins _gates_to_orexins

View Results

Experiment #00000077

The use of lysosome-acidifying nanoparticles (AcNPs) could potentially be adapted to treat nanoplastic-induced lysosomal alkalization or membrane rigidification, as these nanoparticles act to restore the degradative capacity lost during environmental contaminant stress.

Nanoplastic exposure _gates_from_nanoplastic_exposure Lysosomes _gates_to_lysosomes _gates_from_lysosomes Autophagy _gates_to_autophagy Nanoparticles _gates_from_nanoparticles Hydrogen-Ion Concentration

View Results

Experiment #00000075

Polystyrene nanoplastics (PS-NPs) may act as a scaffold for the recruitment and accumulation of WDR44 at the lysosomal membrane, thereby accelerating the de novo aggregation of alpha-synuclein in the early stages of PD.

Nanoplastic exposure _gates_from_nanoplastic_exposure Lysosomal Storage Diseases _gates_to_lysosomal_storage_diseases _gates_from_lysosomal_storage_diseases alpha-Synuclein _gates_to_alpha_synuclein WDR44 _gates_from_wdr44 Protein Aggregates

View Results

Experiment #00000074

OGT (O-GlcNAc transferase) modulation via pharmacological agonists can prevent degeneration of cranial nerves following traumatic or surgical stress.

Trauma/Stress _gates_from_trauma_stress Ferritinophagy/Oxidative Stress _gates_to_ferritinophagy_oxidative_stress Autophagy _gates_from_autophagy N-Acetylglucosaminyltransferases _gates_to_n_acetylglucosaminyltransferases _gates_from_n_acetylglucosaminyltransferases Neuronal Survival

View Results

Experiment #00000070

What types of infections might cause a high C-Reactive Protein result?

Pathogen presence _gates_from_pathogen_presence Immunity, Innate _gates_to_immunity__innate _gates_from_immunity__innate C-Reactive Protein _gates_to_c_reactive_protein _gates_from_c_reactive_protein Biomarkers _gates_to_biomarkers

View Results

Experiment #00000067

Frontotemporal dementia; Splicing; TDP-43; Transcriptomics.

DNA-Binding Protein-43 _gates_from_dna_binding_protein_43 RNA Splicing _gates_to_rna_splicing _gates_from_rna_splicing Neuronal dysfunction _gates_to_neuronal_dysfunction Exons _gates_to_exons Splicing defects

View Results

Experiment #00000062

NESCO-induced pyroptosis in the peritoneal microenvironment might be attenuated by the upregulation of 11-oxygenated androgens in the systemic circulation.

Endometriosis _gates_from_endometriosis Tumor Microenvironment _gates_to_tumor_microenvironment Androgens _gates_from_androgens _gates_to_endometriosis Disease Models, Animal _gates_from_disease_models__animal NESCO and Androgens

View Results

Experiment #00000057

Amyotrophic Lateral Sclerosis breakthrough updates as of July 2026

Systemic Disease _gates_from_systemic_disease Gene Expression Regulation _gates_to_gene_expression_regulation

View Results

Experiment #00000053

How do specific microbial-derived metabolites, beyond short-chain fatty acids and bile acids, function as 'molecular switches' to program hepatic lipid metabolism during the earliest stages of steatotic liver disease?

Microbial composition _gates_from_microbial_composition Metabolomics _gates_to_metabolomics _gates_from_metabolomics Signal Transduction _gates_to_signal_transduction Host signaling _gates_from_host_signaling Lipid Metabolism

View Results

Experiment #00000050

What are the symptoms of toxoplasmosis and how is it transmitted?

Host _gates_from_host Infection _gates_to_infection _gates_from_infection Clinical Symptoms _gates_to_clinical_symptoms Animals, Domestic _gates_from_animals__domestic Environment

View Results

Experiment #00000049

Explain the risks of veridical AI and human job displacement.

Artificial Intelligence _gates_from_artificial_intelligence Efficiency, Organizational _gates_to_efficiency__organizational _gates_from_efficiency__organizational Employment _gates_to_employment _gates_from_employment Patient-Centered Care _gates_to_patient_centered_care

View Results

Experiment #00000048

The ALS-T2D comorbidity is driven by a bidirectional, exosome-mediated proteostatic collapse. Peripheral tissues (muscle, pancreas) dictate CNS TDP-43 stability via exosomal miRNAs (miR-126a-5p) and glucose-dependent modifications (O-GlcNAcylation). Conversely, pharmacological activation of ubiquitin-peptidases (e.g., Acarbose targeting USP46) or restitution of glycolytic cofactors (F2,6BP) represent novel, cross-disciplinary therapeutic targets capable of halting systemic proteinopathy.

Diabetes Mellitus, Type 2 _gates_from_diabetes_mellitus__type_2 Extracellular Vesicles _gates_to_extracellular_vesicles _gates_from_extracellular_vesicles DNA-Binding Proteins _gates_to_dna_binding_proteins _gates_from_dna_binding_proteins Amyotrophic Lateral Sclerosis _gates_to_amyotrophic_lateral_sclerosis

View Results

Experiment #00000045

Sporadic ALS and C9orf72 affected ALS are two different pathologies and the mixing of test groups and datasets has produced confounding results.

Molecular Heterogeneity _gates_from_molecular_heterogeneity Diagnostic Errors _gates_to_diagnostic_errors Biomarkers _gates_to_biomarkers Genetic Heterogeneity _gates_from_genetic_heterogeneity Molecular Typing _gates_to_molecular_typing

View Results

Experiment #00000044

What kinds of changes in voice occur prior to Amyotrophic Lateral Sclerosis onset?

Amyotrophic Lateral Sclerosis _gates_from_amyotrophic_lateral_sclerosis Bulbar Palsy _gates_to_bulbar_palsy _gates_from_bulbar_palsy Speech _gates_to_speech _gates_from_speech Missing _gates_to_missing

View Results

Experiment #00000043

Subject-specific prognostic models can now predict articulatory precision and ALSFRS-R speech subscores 30–90 days in advance.

Speech-Language Pathology _gates_from_speech_language_pathology Algorithms _gates_to_algorithms _gates_from_algorithms Amyotrophic Lateral Sclerosis _gates_to_amyotrophic_lateral_sclerosis Speech _gates_from_speech Bulbar Palsy

View Results

Experiment #00000041

What is the biological/molecular pathway that causes sarcopenia with the scope of COPD? Do the quads serve as a pathological progression indicator?

Pulmonary Disease, Chronic Obstructive _gates_from_pulmonary_disease__chronic_obstructive Systemic Inflammatory Response Syndrome _gates_to_systemic_inflammatory_response_syndrome _gates_from_systemic_inflammatory_response_syndrome Signal Transduction _gates_to_signal_transduction _gates_from_signal_transduction Muscular Atrophy _gates_to_muscular_atrophy

View Results

Experiment #00000039

What is the current evidence for RGNEF (ARHGEF28) functioning as a primary upstream regulator of axonal transport and TDP-43 homeostasis in ALS, and how does the failure of this 'terminal tether' initiate the pathological continuum compared to downstream protein aggregation?

Metabolic Stress _gates_from_metabolic_stress Protein Aggregation _gates_to_protein_aggregation _gates_from_protein_aggregation RNA Metabolism _gates_to_rna_metabolism _gates_from_rna_metabolism Axonal Transport _gates_to_axonal_transport

View Results

Experiment #00000038

Map the direct mechanical and axonal transport pathways connecting intranasal administration or trigeminal nerve delivery to the clearance of TDP-43 aggregates in sporadic ALS, and the delivery of CRISPR-Cas/ASO gene therapies targeting C9orf72 hexanucleotide repeat expansions in the cerebellum and brainstem.

Intranasal Route _gates_from_intranasal_route Blood-Brain Barrier _gates_to_blood_brain_barrier C9orf72 Protein _gates_to_c9orf72_protein _gates_from_c9orf72_protein Brain _gates_to_brain Intranasal Administration

View Results

Experiment #00000036

What is Karyoptosis and how does it align with past and present neurodegenerative disease research? Does Karyoptosis provide a new context in which a new class of repurposed therapeutics is formed?

Proteotoxic Stress _gates_from_proteotoxic_stress Cyclic AMP-Response Element Binding Protein _gates_to_cyclic_amp_response_element_binding_protein _gates_from_cyclic_amp_response_element_binding_protein Nuclear Envelope _gates_to_nuclear_envelope _gates_from_nuclear_envelope Apoptosis _gates_to_apoptosis

View Results

Experiment #00000035

What changes in a person's voice occur prior to Amyotrophic Lateral Sclerosis onset that may be useful as a non-clinical (or clinical if possible) early detection of the disease?

Motor Neuron Disease _gates_from_motor_neuron_disease Muscle Weakness _gates_to_muscle_weakness _gates_from_muscle_weakness Vocal Cord Dysfunction _gates_to_vocal_cord_dysfunction Quantitative Analysis _gates_from_quantitative_analysis Biomarkers

View Results

Experiment #00000034

Is cannabis a hyperaccumulator of metals such as Cadmium?

Cannabis sativa _gates_from_cannabis_sativa Biodegradation _gates_to_biodegradation _gates_from_biodegradation Hyperaccumulation status _gates_to_hyperaccumulation_status Metals, Heavy _gates_to_metals__heavy _gates_from_metals__heavy

View Results

Experiment #00000033

Acinetobacter baumannii and Pseudomonas may share pathways with other pathologies and there may be therapeutic bacteriophages or other non-antibiotic solutions hidden with in PubMed literature.

Drug Resistance, Multiple, Bacterial _gates_from_drug_resistance__multiple__bacterial Anti-Bacterial Agents _gates_to_anti_bacterial_agents Multidrug resistance _gates_from_multidrug_resistance Therapeutics _gates_to_therapeutics Biofilms _gates_from_biofilms

View Results

Experiment #00000031

Why are frontotemporal dementia and c9orf72 ALS considered different diseases if they are both driven by the same abnormal expansion of a GGGGCC (G₄C₂) sequence in the first intron of the C9orf72 gene? Is it logical to think that CRISPR therapeutics for FTD potentially be used for ALS as well?

C9orf72 expansion _gates_from_c9orf72_expansion Gene Expression Regulation _gates_to_gene_expression_regulation _gates_from_gene_expression_regulation Protein Aggregation, Pathological _gates_to_protein_aggregation__pathological _gates_from_protein_aggregation__pathological CRISPR-Cas Systems _gates_to_crispr_cas_systems

View Results

Experiment #00000028

Are there any vitamins or supplements that have either old or recent clinical trial evidence of being beneficial for preventing or reducing migraines that may have been overlooked? I cannot afford the current migraine medications.

Dietary Factors _gates_from_dietary_factors Mitochondrial Dysfunction _gates_to_mitochondrial_dysfunction _gates_from_mitochondrial_dysfunction Hyperacusis _gates_to_hyperacusis Neurogenic Inflammation _gates_from_neurogenic_inflammation Dietary Supplements

View Results

Experiment #00000026

Can post-lyme disease syndrome be cured?

Lyme Disease _gates_from_lyme_disease Anti-Bacterial Agents _gates_to_anti_bacterial_agents _gates_from_anti_bacterial_agents Post-Treatment Lyme Disease Syndrome _gates_to_post_treatment_lyme_disease_syndrome _gates_from_post_treatment_lyme_disease_syndrome 10-20% of cases _gates_to_10_20__of_cases

View Results

Experiment #00000024

If RGNEF fails agitate and regulate TDP-43 at the RGNEF NF242 Terminal, does this cause TDP-43 propteinopathy?

Protein Interaction Mapping _gates_from_protein_interaction_mapping RNA Stability _gates_to_rna_stability Peptide Fragments _gates_from_peptide_fragments RNA Recognition Motif _gates_to_rna_recognition_motif Metabolic stress _gates_from_metabolic_stress

View Results

Experiment #00000021

How long until I can sleep on my side after knee replacement surgery?

Arthroplasty, Replacement, Knee _gates_from_arthroplasty__replacement__knee Postural Balance _gates_to_postural_balance _gates_from_postural_balance Range of Motion, Articular _gates_to_range_of_motion__articular

View Results

Experiment #00000019

What is the role of 3-indolepropionic acid within the body, and what foods or nutrients may help replenish it if deficient?

Edible Grain _gates_from_edible_grain Clostridium sporogenes _gates_to_clostridium_sporogenes Gastrointestinal Microbiome _gates_from_gastrointestinal_microbiome 3-indolepropionic acid _gates_to_3_indolepropionic_acid _gates_from_3_indolepropionic_acid Signal Transduction

View Results

Experiment #00000016

Analyze the potential for zinc-binding competition between synaptic transporters (e.g., SLC39A8, ZnT3) and ALS-associated proteins (RGNEF, TDP-43) in the RGC-thalamic axis. Can this competition explain the coexistence of RGC excitotoxicity and STMN2 depletion in clinical samples?

TAR DNA-Binding Protein 43 _gates_from_tar_dna_binding_protein_43 Stathmin 2 _gates_to_stathmin_2 SLC39A8 protein, human _gates_from_slc39a8_protein__human Zinc _gates_to_zinc Excitotoxicity _gates_from_excitotoxicity

View Results

Experiment #00000015

Given that schizophrenia is characterized by a deficit in the attenuation of sensory input via corollary discharge, how might pathologically elevated RGC signaling—potentially caused by synaptic glutamate overflow without zinc modulation—interfere with the thalamic integration of extra-retinal CD signals to effectively reverse the predictive timing of visual stability?

SLC39A8 Protein _gates_from_slc39a8_protein Zinc Deficiency _gates_to_zinc_deficiency _gates_from_zinc_deficiency Glutamic Acid _gates_to_glutamic_acid _gates_from_glutamic_acid Thalamus _gates_to_thalamus

View Results

Experiment #00000012

If a toxin with a thermodynamic affinity for Zinc GREATER THAN that of Glutamate AND LESS THAN that of RGNEF, under certain conditions a pathway exists wherein the toxin could shuttle synaptic retinal zinc to RGNEF, thus potentially ultimately resulting in the retinal TDP-43 proteinopathy seen in the retina post mortem in Sporadic Amyotrophic Lateral Sclerosis

Synaptic Zinc _gates_from_synaptic_zinc Receptors, Glutamate _gates_to_receptors__glutamate _gates_from_receptors__glutamate Zinc Dyshomeostasis in RGCs _gates_to_zinc_dyshomeostasis_in_rgcs _gates_from_zinc_dyshomeostasis_in_rgcs TDP-43 Proteinopathy _gates_to_tdp_43_proteinopathy

View Results

Experiment #00000010

How long after a tick bite does it take before Lyme disease can be detected by a blood test?

Tick Bite _gates_from_tick_bite Infection/Colonization _gates_to_infection_colonization _gates_from_infection_colonization Serologic Tests _gates_to_serologic_tests _gates_from_serologic_tests False Negative Reactions _gates_to_false_negative_reactions

View Results

Experiment #00000007

Simply put, we still don’t know why neurons are dying in ALS, and why motor neurons die while other types of neurons don’t. Even for genetic forms c9orf72 familial ALS, why is it that the mutation is in every cell but the motor neurons are dying ie have increased susceptibility?

Axonal Transport _gates_from_axonal_transport Motor Neuron Disease _gates_to_motor_neuron_disease C9orf72 Repeat Expansion _gates_from_c9orf72_repeat_expansion Dipeptide Repeats _gates_to_dipeptide_repeats _gates_from_dipeptide_repeats VAPB protein, human

View Results

PathMap Literature Based Discovery Engine

Guaranteed to find unpublished literature based discoveries.

Prenatal iron deficiency (ID) exacerbates the risk of sudden infant death syndrome (SIDS) by modulating the expression of the hypothalamic orexin system, impairing homeostatic arousal mechanisms during hypoxia.

The use of lysosome-acidifying nanoparticles (AcNPs) could potentially be adapted to treat nanoplastic-induced lysosomal alkalization or membrane rigidification, as these nanoparticles act to restore the degradative capacity lost during environmental contaminant stress.

Polystyrene nanoplastics (PS-NPs) may act as a scaffold for the recruitment and accumulation of WDR44 at the lysosomal membrane, thereby accelerating the de novo aggregation of alpha-synuclein in the early stages of PD.

OGT (O-GlcNAc transferase) modulation via pharmacological agonists can prevent degeneration of cranial nerves following traumatic or surgical stress.

What types of infections might cause a high C-Reactive Protein result?

Frontotemporal dementia; Splicing; TDP-43; Transcriptomics.

NESCO-induced pyroptosis in the peritoneal microenvironment might be attenuated by the upregulation of 11-oxygenated androgens in the systemic circulation.

Amyotrophic Lateral Sclerosis breakthrough updates as of July 2026

How do specific microbial-derived metabolites, beyond short-chain fatty acids and bile acids, function as 'molecular switches' to program hepatic lipid metabolism during the earliest stages of steatotic liver disease?

What are the symptoms of toxoplasmosis and how is it transmitted?

Explain the risks of veridical AI and human job displacement.

Sporadic ALS and C9orf72 affected ALS are two different pathologies and the mixing of test groups and datasets has produced confounding results.

What kinds of changes in voice occur prior to Amyotrophic Lateral Sclerosis onset?

Subject-specific prognostic models can now predict articulatory precision and ALSFRS-R speech subscores 30–90 days in advance.

What is the biological/molecular pathway that causes sarcopenia with the scope of COPD? Do the quads serve as a pathological progression indicator?

What is the current evidence for RGNEF (ARHGEF28) functioning as a primary upstream regulator of axonal transport and TDP-43 homeostasis in ALS, and how does the failure of this 'terminal tether' initiate the pathological continuum compared to downstream protein aggregation?

What is Karyoptosis and how does it align with past and present neurodegenerative disease research? Does Karyoptosis provide a new context in which a new class of repurposed therapeutics is formed?

What changes in a person's voice occur prior to Amyotrophic Lateral Sclerosis onset that may be useful as a non-clinical (or clinical if possible) early detection of the disease?

Is cannabis a hyperaccumulator of metals such as Cadmium?

Acinetobacter baumannii and Pseudomonas may share pathways with other pathologies and there may be therapeutic bacteriophages or other non-antibiotic solutions hidden with in PubMed literature.

Why are frontotemporal dementia and c9orf72 ALS considered different diseases if they are both driven by the same abnormal expansion of a GGGGCC (G₄C₂) sequence in the first intron of the C9orf72 gene? Is it logical to think that CRISPR therapeutics for FTD potentially be used for ALS as well?

Are there any vitamins or supplements that have either old or recent clinical trial evidence of being beneficial for preventing or reducing migraines that may have been overlooked? I cannot afford the current migraine medications.

Can post-lyme disease syndrome be cured?

If RGNEF fails agitate and regulate TDP-43 at the RGNEF NF242 Terminal, does this cause TDP-43 propteinopathy?

How long until I can sleep on my side after knee replacement surgery?

What is the role of 3-indolepropionic acid within the body, and what foods or nutrients may help replenish it if deficient?

Analyze the potential for zinc-binding competition between synaptic transporters (e.g., SLC39A8, ZnT3) and ALS-associated proteins (RGNEF, TDP-43) in the RGC-thalamic axis. Can this competition explain the coexistence of RGC excitotoxicity and STMN2 depletion in clinical samples?

How long after a tick bite does it take before Lyme disease can be detected by a blood test?

Simply put, we still don’t know why neurons are dying in ALS, and why motor neurons die while other types of neurons don’t. Even for genetic forms c9orf72 familial ALS, why is it that the mutation is in every cell but the motor neurons are dying ie have increased susceptibility?

See all pathway research

Need a custom Literature-Based Discovery?